Even if the concentration of sex hormones and the expression of sex hormone receptors are among the main risk factors for a higher incidence of prostate cancer, carrying the TCF7L2 rs12255372‐T allele is associated with prostate cancer progression and metastases. This evidence concerns the gene TCF7L2 and prostate carcinoma.